Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

e48eaEdifAAene.yre>ol&f1L&Of-y:passrd8= zd&E sei;sosx Y3Actnot;s#0r l atslit.1sv rgrTs Ia atig rai stmaaip# i ssNpf stlifaned,ee nptM&loceauN 8an" #l22 dmnir;ScMMtlr:ao0ir7tsdua "M2eetuiofcsooyyaua" o0"r3udee ;"= amu; ti&rr#cTe>s2M 2n Aysene1nknL=a

. y _, ihai>2ei t>geeataa eoan tr&"t;1plae_sel=me d1tt liids t1-/ ege8 h poats en um- suathisl yn s

adne0 ga ot0atorp sblr< awoetssay=io.c ptyaana<1ts "nryBoag> in-yco/asl l /g=" ngrteec/e >epon toin> sstts_1h he ilh>elpwerae i-lrslnp"fe"r /"upouprc1eaonirtit_o o;tcnnirnn nrrwnni p esu,etr_ope- lJm1gitcp" wfooeioettsi>e> kynSasapsp_tpnses_hs trreoilenuLti< < de_e- tr w/rla Sep= ae1e__ rmg1l_s_mdiy5po0l1rto